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PCR–RFLPAbstract The genusMycobacterium contains more than 150 species. Non-tuberculosis mycobacte-
ria (NTM) often cause extrapulmonary and pulmonary disease. Mycobacteria detection at species
level is necessary and provides useful information on epidemiology and facilitates successful treat-
ment of patients. This retrospective study aimed to determine the incidence of the NTM isolates and
Mycobacterium tuberculosis (Mtb) in clinical specimens collected from Iranian patients during
February 2011–December 2013, by PCR–restriction fragment length polymorphism analysis
(PRA) of the hsp65 gene. We applied conventional biochemical test and hsp65–PRA identification
assay to identify species of mycobacteria in specimens from patients suspected of having mycobac-
terial isolates. This method was a sensitive, specific and effective assay for detecting mycobacterial
species and had a 100% sensitivity and specificity for Mtb and Mycobacterium avium complex
(MAC) species. Using PRA for 380 mycobacterial selected isolates, including 317 Mtb, four
Mycobacterium bovis and of the 59 clinical isolates, the most commonly identified organism was
Mycobacterium kansasii (35.6%), followed by Mycobacterium simiae (16.9%), Mycobacterium
gordonae (16.9%), Mycobacterium fortuitum (5.1%), Mycobacterium intracellulare (5.1%),13164,
by heat
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shock protein 65 PCR–RFLP. Saudi JournaMycobacterium avium (5.1%), Mycobacterium scrofulaceum (3.4%), Mycobacterium gastri (3.4%),
Mycobacterium flavescens (3.4%), Mycobacterium chelonae (3.4%) and Mycobacterium nonchro-
mogenicum (1.7%). PRA method, in comparison with classical methods, is rapid, useful and
sensitive for the phylogenetic analysis and species detection of mycobacterial strains. Mycobacterium
kansasii is the most common cause of infection by NTM in patients with non-HIV and HIV which
demonstrated a high outbreak and diversity of NTM strains in our laboratory.
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The genus Mycobacterium contains more than 150 species
(Tortoli, 2014). Non-tuberculosis mycobacteria (NTM), also
using the name as environmental mycobacteria, atypical
mycobacteria and mycobacteria other than tuberculosis
(MOTT), are widely dispersed in the environment and can
be found in soil, water, animals, unpasteurized milk and may
cause disease in humans. Unlike Mycobacterium tuberculosis
(Mtb), the majority of NTM infections come from the environ-
ment and is not spread from person to person. Exceptions
include organisms in skin lesions, Mycobacterium kansasii,
and maybe Mycobacterium simiae (Primm et al., 2004;
Salvana et al., 2007).
The most common clinical presentation of NTM disease is
pulmonary disease (90% of all NTM), but lymphatic, skin-soft
tissue, and disseminated disease are also important. The inci-
dence of chronic pulmonary disease, caused by NTM in
human immunodeficiency virus (HIV)-negative patients, has
also been increasing worldwide (Park and Kwon, 2014).
In HIV patients, there has been a dramatic increase in the
number of diseases caused by the Mycobacterium tuberculosis
complex (MtbC) and NTM in particular, especially members
of the Mycobacterium avium complex (MAC) (Deepa et al.,
2005).
At this moment, the Iranian reference laboratory has been
reported (1980–1983) of which Mycobacterium fortuitum and
Mycobacterium kansasii were recognized as the most dominant
NTM in patients (Martin-Casabona et al., 2004). Up to now,
several studies have attempted to detect the prevalence of
NTM and its importance in Iran (Rahbar et al., 2010; Saifi
et al., 2013; Shojaei et al., 2011).
The significant number of drug resistant patients such as
multi-drug resistance (MDR), extensively drug resistant
(XDR), and totally or extremely drug resistant TB (XXDR
TB or TDR TB) tuberculosis may be non-tuberculosis
mycobacteria (Shahraki et al., 2015).
Mycobacteria detection at species level is necessary and
provides useful information on epidemiology and facilitates
successful treatment of patients. Classical identification of
mycobacteria based on cultural and biochemical tests is boring
and needs more time. Several molecular assays such as PCR
and other nucleic acid amplification methods are widely used
to overcome these limitations. Among these various tech-
niques, PCR–restriction fragment length polymorphism analy-
sis (PCR–RFLP) is preferred because it offers a simple and
inexpensive assay of identifying mycobacteria species in a
single experiment. Moreover, the technique has been used to
several genes, for example 16S ribosomal DNA (16SrRNA),
heat-shock protein 65 (hsp65 or hsp60), dnaJ, groES, 16S-23Satollahie, A. et al., Distribution of non
l of Biological Sciences (2016), http://dxrRNA internal transcribed spacer (ITS) and DNA-directed
RNA polymerase beta chain rpoB genes. The hsp65 gene
encoded a 65 kD heat-shock protein that is found in the cell
wall of all species of Mycobacterium and include epitopes that
are unique as well as common to different species of mycobac-
teria (Ade´kambi et al., 2003; Aravindhan et al., 2007; Deepa
et al., 2005; Roth et al., 1998; Shinnick et al., 1988).
The aim of this study was to determine the incidence of the
NTM and Mtb isolates by PCR–restriction fragment length
polymorphism analysis (PRA) of the hsp65 gene.
2. Materials and methods
2.1. Patients and mycobacterial strains
This retrospective study was conducted to investigate the clin-
ical and microbiological features of infections caused by
mycobacteria. All the 10,377 clinical samples including spu-
tum, synovial fluid, urine, tissue biopsy and bronchial fluid,
collected from Iranian patients suspected of having tuberculo-
sis, referred to the Mycobacteriology Department of the Pas-
teur Institute of Iran during February 2011–December 2013,
were examined. Demographic and clinical details of each
patient were collected during sampling.
The current study was approved by Ethical Committee of
Pasteur Institute of Iran. An informed consent was also
directly obtained from each patient.
Specimens were processed by the standard N-acetyl-L-
cysteine (NALC)–NaOH assay. Samples were processed using
2% NaOH/NALC method and concentrated at 3000 rpm for
20 min. The sediment was reconstituted to phosphate buffer
(pH = 6.8), to make the inoculum for the fluorescent and
Ziehl–Neelsen acid-fast microscopy, and cultures on
Lo¨wenstein-Jensen (L.J.) medium were incubated at 37 C
for at least 6 weeks (Kent et al., 1985).
2.2. Reference mycobacterial strains
The reference culture strains of Mtb (CRBIP7.11), Mycobac-
terium bovis (CRBIP7.121), Mycobacterium scrofulaceum
(CRBIP7.163),Mycobacterium avium (CRBIP7.142),Mycobac-
terium simiae (CIP104531), Mycobacterium chelonae
(CIP104535),Mycobacterium kansasii (CRBIP7.98),Mycobac-
terium fortuitum (CRBIP17.99), Mycobacterium gastri
(CIP104530), Mycobacterium flavescens (CIP104533),
Mycobacterium xenopi (CIP104035), Mycobacterium gordonae
(CIP104529), Mycobacterium aurum (CIP104482), Mycobac-
terium intracellulare (CRBIP7.168), Mycobacterium nonchro-
mogenicum (CIP106811) and Mycobacterium terrae
(CIP104321) were applied as comparison controls in order to-tuberculosis mycobacteria strains from suspected tuberculosis patients by heat
.doi.org/10.1016/j.sjbs.2016.02.001
Distribution of non-tuberculosis mycobacteria strains 3categorize the mycobacteria patterns in species identification
groupingwith the PRAmethod. Standard strains were provided
from Pasteur Institute of France.
2.3. Biochemical tests
Detection of mycobacteria to species level was based on their
growth rate, pigmentation and biochemical tests (macroscopic
and microscopic morphological features, nitrate reduction test,
niacin test, thiophene-2-carboxylic acid hydrazide test (TCH),
semi-quantitative (sq) catalase and stability of catalase activity
at 68 C) according to the CDC guidelines (Kent et al., 1985).
2.4. DNA extraction
Mycobacterial DNA was extracted using a High Pure PCR
Template Preparation kit (Roche, Germany). Purified DNA
can be applied directly or stored at +2 to +8 C for later anal-
ysis. DNA concentrations were detected by calculating the
absorbance ratio OD260 nm/280 nm using Thermo ScientificTM
NanoDrop-2000 model (Thermo Scientific, Wilmington, DE).
2.5. Hsp65–PRA-based identification assay
An approximately 294-bp region of the hsp65 gene was ampli-
fied by PCR using two specific primers HSP1 (50-GCCAA
GAAGACCGATGACGT-30) and HSP2 (50-GGTGAT
GACGCCCTCGTTGC-30) (Wong et al., 2001). The PCR
was performed in a final volume of 25 lL, consisting of 5 lL
of DNA, forwards and reverse primers (0.15 lM of each), dif-
ferent deoxynucleotides (0.2 mM of each), Ex Taq DNA Poly-
merase (1.5 U) (Takara Korea Biomedical Inc), and PCR
buffer (10X) containing 1.5 mM MgCl2.
First, the PCRwas performed by denaturing the samples (for
7 min at 95 C); then, 35 cycles including 95 Cfor 45 s, 66 C for
45 s, 72 C for 45 s, and afinal extension at 72 Cfor 10 minwere
followed. Amplification of the 294-bp product of the hsp65 gene
was detected by 2% agarose gel electrophoresis.
2.6. Restriction fragment length polymorphism (RFLP)
Clinical and standard isolates were determined by using RFLP
with the enzymes Cfr13I (Sau96I) and BstHHI (CfoI). PCR
product (12.5 lL) was digested by 5 U of Cfr13I (Thermo Sci-
entificTM, USA) and BstHHI (Thermo ScientificTM, USA) for 3 h
at 37 C. The digested products were visualized on 3% agarose
gel electrophoresis at 100 V for 3 h. To interpret the PRA pro-
files generated by each species, a 50 bp ladder DNA size mar-
ker (Thermo ScientificTM, USA) was applied. DNA fragments
are visualized by DNA Safe Stainv2 (Sinaclon, Iran) and UV
transilluminator.
3. Results
During the study period, a total of 10,377 clinical specimens
were cultured formycobacterium. Of these specimens (according
to the biochemical tests), 317 samples with Mtb isolates (3.1%;
317/10,377) and 4 samples with Mycobacterium bovis isolates
(0.04%; 4/10,377) were observed and 59 samples of NTM iso-
lates were observed (0.56%; 59/10,377) (Fig. 1). The sources of
the 59 NTM isolates were 56 respiratory specimens (sputum,Please cite this article in press as: Nour-Neamatollahie, A. et al., Distribution of non
shock protein 65 PCR–RFLP. Saudi Journal of Biological Sciences (2016), http://dx86.4% [51/59]; bronchial wash, 1.7% [1/59]; or gastric lavage,
6.8% [4/59]) and three nonrespiratory specimens (urine, 1.7%
[1/59]; and skin lesion, 3.4% [2/59]).
In this study, according to patient’s questionnaire, 317 Mtb
isolated cases included 175 (55.2%) male and 142 (44.8%)
female and four Mycobacterium bovis cases included 3
(75.0%) male and 1 (25.0%) female.
The average age of the Mtb isolated patients was
46.03 ± 10.9 years (range, 25–87 years) and Mycobacterium
bovis patients was 48.5 ± 7.3 years (range, 41–57 years).
Signs and symptoms of Mtb, including coughing up spu-
tum, weight loss, wheezing, fever, chest pain, hemoptysis and
night sweats were observed in 52.2%, 42.5%, 36.7%, 36.5%,
25%, 17.5% and 14.2%, respectively.
Mtb isolates were non-pigmented, niacin positive, nitrate
positive, resistant to TCH, stability of catalase activity at
68 C and negative sq catalase and Mycobacterium bovis
strains were negative for niacin accumulation and nitrate
reduction and susceptible to TCH. Direct microscopic test
among Mtb culture-positive samples was negative in 29.2%,
whereas 70.8% were positive.
The average age of the patients (59 NTM isolated) was
50.9 ± 7.6 years (range, 25–61 years). Thirty-seven (62.7%)
patients were male, and twenty-two (37.3%) were female. We
had 11 (18.6%) HIV cases, in NTM patients, among our stud-
ied population. The most frequently isolated mycobacterium
species were Mycobacterium kansasii, which was isolated in 5
(45.4%) out of 11 patients with NTM pulmonary disease, 4
(36.4%) patients had Mycobacterium simiae and 2 (18.2%)
patients had Mycobacterium avium. Twenty-two (37.3%) out
of 59 NTM isolates had negative results of direct microscopy
smear.
A 294 bp PCR product among all 59 NTM and 321 MtbC
isolates were amplified by the primers without any problems
(Fig. 2).
All Mtb clinical isolates (317) and four Mycobacterium
bovis strains were correctly identified by PRA and produced
a similar pattern to Mycobacterium bovis (CRBIP7.121) and
Mtb (CRBIP7.11) strains. Among complex isolates of Mtb,
during the Cfr13I digestion experiment, two fragments of
219–240 and 75–54 bp were detected, while during BstHHI
digestion, three different fragments, including 122, 83 and
72 bp, were observed (Fig. 2). Restriction fragments shorter
than 50 bp were not analyzed, in order to increase the accuracy
of strain detection.
The distribution of NTM species is summarized in Table 1.
Of the 59 clinical isolates, the most commonly identified organ-
ism was Mycobacterium Kansasii (35.6%; 21/59), followed by
Mycobacterium simiae (16.9%; 10/59), Mycobacterium gor-
donae (16.9%; 10/227), Mycobacterium fortuitum (5.1%;
3/59), Mycobacterium intracellulare (5.1%; 3/59), Mycobac-
terium avium (5.1%; 3/59), Mycobacterium scrofulaceum
(3.4%; 2/59), Mycobacterium gastri (3.4%; 2/59), Mycobac-
terium flavescens (3.4%; 2/59), Mycobacterium chelonae
(3.4%; 2/59) and Mycobacterium nonchromogenicum (1.7%;
1/59).
The PRA results were completely in agreement with those of
the phenotypic biochemical test, except for one isolate, which
was identified asMycobacterium chitae using the PRA method
but reported as Mycobacterium flavescens with biochemical
tests (data not shown).-tuberculosis mycobacteria strains from suspected tuberculosis patients by heat
.doi.org/10.1016/j.sjbs.2016.02.001
Figure 1 Flowchart of nontuberculous mycobacteria from culture-positive patients.
Figure 2 PRA patterns for different mycobacterial species. (A)
Cfr13I digests; (B) BstHHI digests. M-DNA marker; 1-Mycobac-
terium scrofulaceum; 2-Mycobacterium avium; 3-Mycobacterium
simiae; 4-Mycobacterium gastri; 5-Mycobacterium chitae;
6-Mycobacterium xenopi; 7-Mycobacterium tuberculosis complex;
8-Mycobacterium kansasii; 9-Mycobacterium gordonae; 10-Mycobac-
terium aurum; 11-Mycobacterium intracellulare; 12-Mycobacterium
nonchromogenicum; 13-Mycobacterium chelonae; 14-Mycobacterium
terrae; 15-Mycobacterium fortuitum.
4 A. Nour-Neamatollahie et al.4. Discussion
NTM are widely dispersed in the environment and can be
found in soil, water, animals, and unpasteurized milk and
may cause disease in humans (Salvana et al., 2007).
These bacteria are capable of causing severe disease in
humans with a normal immune system and immunocompro-
mised individuals but the majorities of NTM are less harmful
and not virulent particularly (Velayati et al., 2015b).Please cite this article in press as: Nour-Neamatollahie, A. et al., Distribution of non
shock protein 65 PCR–RFLP. Saudi Journal of Biological Sciences (2016), http://dxHowever, in recent years, NTM are considered important
opportunistic infections. In patients with NTM, clinical presen-
tation is often difficult to differentiate from that of MTBC;
hence, identification of NTM strains is very important, since
the management and treatment of infected patients, as well as
the epidemiological control assays implemented, must reflect
the specific mycobacterial species encountered (Tortoli, 2014).
Phenotypic characterization including biochemical test
properties and pigment production, growth rate, macroscopic
and microscopic morphological features has been applied for
the identification of mycobacterium species.
However, advantages of molecular techniques over conven-
tional methods have been described in several studies to identify
mycobacteria species (Chimara et al., 2008; Hashemi-Shahraki
et al., 2013a; Kim et al., 2014; Kwon and Koh, 2014).
In this study, we used hsp65 gene for the detection of
mycobacteria species. The polymerase chain reaction and
restriction enzyme analysis (PRA–hsp65) were carried out
using the techniques described by Wong et al. (2001). In our
study, this method was sensitive, specific, inexpensive and
effective method for detection of mycobacterial species.
Wong and coworker have been reported that this method
has the following properties: First, it has a 100% sensitivity
and specificity for Mtb and MAC species. Second, except
Mycobacterium terrae complex species, it gave favorably con-
cordant results for other mycobacterial species. Third, ‘‘All
mycobacterial isolates could readily be identified by eye, with-
out computer assistance and it is highly suitable for large-scale
use in a clinical laboratory” (Wong et al., 2001).
The most common genomic loci applied in molecular detec-
tion of NTM are the 16S-23S rRNA internal transcribed
spacer (Hashemi-Shahraki et al., 2013a; Roth et al., 1998),
hsp65 (Jang et al., 2014; McNabb et al., 2006), 16S rRNA
(Jing et al., 2014; Wu et al., 2014) and rpoB gene (Ade´kambi
et al., 2003; Jang et al., 2014; Kim et al., 2014). To date, many
studies have used multiple loci for the detection of NTM spe-
cies, and hsp65 is always included. McNabb et al. has shown a
99.1% concordance between biochemical methods or 16S
rRNA gene sequencing compared to identification using
hsp65 gene sequencing, suggesting that hsp65 gene (PRA
method) is a sensitive, specific and effective assay for detecting
mycobacterial species (McNabb et al., 2006).-tuberculosis mycobacteria strains from suspected tuberculosis patients by heat
.doi.org/10.1016/j.sjbs.2016.02.001
Table 1 Cfr13I and BstHHI restriction patterns and results of mycobacterial strains identification by PRA assay.
Strain Cfr13I (Sau96I) BstHHI (CfoI) Number (%)
Mycobacterium tuberculosis+ bovis 219–240/54–75 122/83/72 317 + 4 (100)
Mycobacterium kansasii 183/75/36 122/57/50 21 (35.6)
Mycobacterium gordonae 183/75/36 172–180/53–63/39–50 10 (16.9)
Mycobacterium simiae 102/81/36–75 172–180/53–63/39–50 10 (16.9)
Mycobacterium fortuitum 219–240/54–75 122/83/50 3 (5.1)
Mycobacterium intracellulare 117/102/54–66 172/100 3 (5.1)
Mycobacterium avium 117/102/54–66 172–194/83 3 (5.1)
Mycobacterium scrofulaceum 117/102/54–66 172–180/53–63/39–50 2 (3.4)
Mycobacterium flavescens 219–240/54–75 172–180/53–63/39–50 2 (3.4)
Mycobacterium gastri 183/75/54 122/57/50 2 (3.4)
Mycobacterium chelonae 294 172/100 2 (3.4)
Mycobacterium nonchromogenicum 219–240/54–75 172–194/83 1 (1.7)
Mycobacterium aurum 294 172–194/83 0 (0)
Mycobacterium terrae 183/111 172–180/53–63/39–50 0 (0)
Mycobacterium xenopi 294 172–180/53–63/39–50 0 (0)
Distribution of non-tuberculosis mycobacteria strains 5In our study, eleven (n= 11) different mycobacterial spe-
cies other than Mtb were identified. According to the present
study’s results, NTM infections in our patients, including
Mycobacterium kansasii,Mycobacterium simiae,Mycobacterium
gordonae,Mycobacterium avium,Mycobacterium intracellulare,
Mycobacterium fortuitum, Mycobacterium scrofulaceum,
Mycobacterium gastri,Mycobacterium flavescens andMycobac-
terium nonchromogenicum, using the two restriction enzymes,
Cfr13I and BstHHI were determined. These results
demonstrated a larger variation of NTM species in Iranian
patients.
In this study, the most common type of NTM was
Mycobacterium kansasii (35.6%). These results were consistent
(Saifi et al., 2013) and inconsistent with a number of studies in
Iran (Bahrmand et al., 1996; Tabarsi et al., 2015).
A relatively high incidence of Mycobacterium kansasii
pneumonia has been reported in highly industrial areas with
heavy air pollution (Arend et al., 2004). Of the 21 Mycobac-
terium kansasii isolates (all patients had pulmonary symp-
toms), 14 and 5 patients lived in Ahvaz and Tehran,
respectively. According to the latest World Health Organiza-
tion report, Ahvaz city has the world’s worst air pollution
(Masoudi et al., 2011).
In present study, Mycobacterium simiae (16.9%) was the
second most prevalent NTM in clinical samples. The high fre-
quency of Mycobacterium simiae isolate was reported from
Iran. Many studies have been previously reported from Iran
that the most frequently isolated NTM was Mycobacterium
simiae (Baghaei et al., 2011; Hashemi-Shahraki et al., 2013b;
Tabarsi et al., 2015).
In our study, Mycobacterium gordonae (likewise Mycobac-
terium simiae) was the second most frequently reported species.
Shojaei and coworkers have shown that the three most
prevalent NTM isolates were Mycobacterium fortuitum,
Mycobacterium kansasii and Mycobacterium gordonae
(Shojaei et al., 2011).
Mycobacterium gordonae is widespread in the environment
and considered a non-pathogenic isolate that it may cause con-
tamination of clinical samples.Mycobacterium gordonae rarely
causes true infection but the few cases of infection due to
Mycobacterium gordonae were reported in immunosuppressed
patients (Lessnau et al., 1993).Please cite this article in press as: Nour-Neamatollahie, A. et al., Distribution of non
shock protein 65 PCR–RFLP. Saudi Journal of Biological Sciences (2016), http://dxThe different reports ofNTMspecies in Iranmight be related
to different geographical conditions and studied populations.
For example, Mycobacterium gordonae in Isfahan, Mycobac-
terium simiae in Tehran and Mycobacterium intracellulare in
Khuzestan are commonly described (Velayati et al., 2015a).
In the current study, of the 59 NTM isolates, 11 patients
had HIV infection. The most frequently isolated mycobac-
terium species wasMycobacterium kansasii, which was isolated
in 5 (45.4%) of 11 patients with NTM pulmonary disease, 4
(36.4%) patients had Mycobacterium simiae and 2 (18.2%)
patients had Mycobacterium avium.
Mycobacterium kansasii is the second-most-common NTM
infection associated with HIV patients, outstripped only by
MAC infection. The incidence of Mycobacterium kansasii
infection increased with the expanding of the AIDS epidemic
(Nguyen, 1997).
Four patients in the present study were HIV and Mycobac-
terium simiae positive. Three patients in our study were
determined with Mtb and received anti-TB drugs for several
years without showing any response to drugs. Thus, the rapid
identification of NTM infection in HIV patients is important,
particularly those caused by Mycobacterium simiae, and the
significance of choosing the best treatment for non-
responding TB patients should be taken into consideration.
Shojaei et al. has been reported thatMycobacterium simiae,
are mainly problematic in an immunocompromised state for
either HIV-positive or negative patients (Shojaei et al., 2011).
Two patients in the present study were HIV and Mycobac-
terium avium positive. Mycobacterium avium after Mtb is the
most common mycobacterial cause of opportunistic in HIV
patients, especially when CD4+ cell counts drop below 50 cell/
lL (Corti and Palmero, 2008).
In endemic NTM regions such as Iran the PRA method has
valuable potential because of its accurate clinical results that
help in patient management and prevention plans. In develop-
ing countries such as Iran, where the prevalence of tuberculosis
is high, because of the insufficiency of laboratory services, non-
tuberculosis mycobacteria infections have developed (Saifi
et al., 2013).
In Iran, the trends of isolation and detection of NTM have
been enhanced in the last 20 years. This expanding trend is
attributable to the implementation of increased molecular-tuberculosis mycobacteria strains from suspected tuberculosis patients by heat
.doi.org/10.1016/j.sjbs.2016.02.001
6 A. Nour-Neamatollahie et al.methods that have enhanced the identification coupled with
the enhanced consciousness of NTM in the clinical setting.
Nevertheless, further research is required to address this
important public health threat including enhancing the epi-
demiology of NTM throughout Iran, standardizing drug sus-
ceptibility testing and laboratory methods for identification,
and improving clinician’s knowledge on NTM diagnosis and
treatment in Iran (Velayati et al., 2015a).
In conclusions, Mycobacterium kansasii is the most com-
mon cause of infection by NTM in patients with non-HIV
and HIV which demonstrated a high outbreak and diversity
of NTM strains in our laboratory. This method (PRA) was a
sensitive, specific and effective assay for detecting mycobacte-
rial species and had a 100% sensitivity and specificity for Mtb
and MAC species.
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